# Anxiety Disorders

## Definition & Classification

**Anxiety Disorders**: A group of mental health conditions characterized by excessive fear, worry, and related behavioral disturbances that cause significant distress or impairment in social, occupational, or other important areas of functioning.

### Classification Systems

**DSM-5 Anxiety Disorders**:
- **Generalized Anxiety Disorder (GAD)**: Excessive anxiety and worry about various events or activities, occurring more days than not for at least 6 months
- **Panic Disorder**: Recurrent unexpected panic attacks and persistent concern about having additional attacks
- **Social Anxiety Disorder (Social Phobia)**: Marked fear or anxiety about social situations in which the individual is exposed to possible scrutiny by others
- **Specific Phobia**: Marked fear or anxiety about a specific object or situation
- **Agoraphobia**: Fear or anxiety about situations where escape might be difficult or help unavailable in the event of panic symptoms
- **Separation Anxiety Disorder**: Developmentally inappropriate and excessive fear or anxiety concerning separation from attachment figures

**Related Disorders**:
- **Obsessive-Compulsive Disorder (OCD)**: Presence of obsessions, compulsions, or both
- **Post-Traumatic Stress Disorder (PTSD)**: Development of characteristic symptoms following exposure to traumatic event(s)
- **Acute Stress Disorder**: Similar to PTSD but occurring within 1 month of trauma exposure

**Severity Classification**:
- **Mild**: Minimal symptoms beyond diagnostic threshold, minor functional impairment
- **Moderate**: Intermediate between mild and severe
- **Severe**: Multiple symptoms in excess of diagnostic criteria, marked functional impairment

## Required Evidence

### Minimum Documentation

1. **Diagnostic confirmation**:
   - Mental health provider's diagnosis and notes
   - Symptom duration and severity
   - Functional impact assessment
   - Screening tool scores (GAD-7, HADS, etc.)

2. **Treatment information**:
   - Current medications and dosages
   - Duration of current treatment
   - Previous medication trials
   - Psychotherapy type and frequency
   - Treatment compliance
   - Response to treatment

3. **Course of illness**:
   - Age at onset
   - Progression of symptoms
   - Exacerbating factors
   - Hospitalization history
   - Pattern of symptoms (episodic vs. continuous)

4. **Risk assessment**:
   - Panic attacks (frequency, severity)
   - Avoidance behaviors
   - Substance use
   - Occupational impact
   - Social functioning
   - Comorbid depression

5. **Medical context**:
   - Medical conditions that may contribute to anxiety
   - Medications that may cause anxiety symptoms
   - Family history of anxiety disorders

### Additional Evidence for Complex Cases

- Psychiatric hospitalization records
- Disability documentation
- Neuropsychological testing results
- Treatment-resistant anxiety management plan
- Substance use assessment

## Rating Guidelines

### Generalized Anxiety Disorder (GAD)

| Severity | Treatment Status | Duration of Stability | Points |
|----------|------------------|----------------------|--------|
| Mild | Well-controlled | <6 months | 0 to +25 points |
| Mild | Well-controlled | >6 months | 0 to +25 points |
| Mild | No treatment, minimal symptoms | Any | 0 to +25 points |
| Moderate | Well-controlled | <6 months | +25 to +50 points |
| Moderate | Well-controlled | 6-12 months | 0 to +25 points |
| Moderate | Well-controlled | >12 months | 0 to +25 points |
| Moderate | Partially controlled | Any | +50 to +75 points |
| Severe | Well-controlled | <12 months | +50 to +75 points |
| Severe | Well-controlled | 1-2 years | +25 to +50 points |
| Severe | Well-controlled | >2 years | 0 to +25 points |
| Severe | Partially controlled | Any | +50 to +75 points |

**Modifying Factors**:
- First episode: -25 points
- Multiple medication trials needed: +25 points
- Consistent follow-up with provider: -25 points
- Poor treatment compliance: +25 points
- Ongoing functional impairment: +25 to +50 points

### Panic Disorder

| Attack Frequency | Treatment Status | Duration of Stability | Points |
|------------------|------------------|----------------------|--------|
| Rare (<1/month) | Well-controlled | <6 months | +25 to +50 points |
| Rare (<1/month) | Well-controlled | 6-12 months | 0 to +25 points |
| Rare (<1/month) | Well-controlled | >12 months | 0 to +25 points |
| Occasional (1-4/month) | Well-controlled | <6 months | +50 to +75 points |
| Occasional (1-4/month) | Well-controlled | 6-12 months | +25 to +50 points |
| Occasional (1-4/month) | Well-controlled | >12 months | 0 to +25 points |
| Frequent (>4/month) | Well-controlled | <12 months | +50 to +75 points |
| Frequent (>4/month) | Well-controlled | 1-2 years | +50 to +75 points |
| Frequent (>4/month) | Well-controlled | >2 years | +25 to +50 points |
| Any frequency | Partially controlled | Any | Add +25 to +50 points to above |
| With agoraphobia | Any | Any | Add +25 to +50 points to above |

**Modifying Factors**:
- ER visits for panic attacks: +25 points
- Significant avoidance behaviors: +25 points
- Consistent follow-up with provider: -25 points
- Poor treatment compliance: +25 points
- Comorbid depression: +25 to +50 points

### Social Anxiety Disorder

| Severity | Treatment Status | Duration of Stability | Points |
|----------|------------------|----------------------|--------|
| Mild | Well-controlled | Any | 0 to +25 points |
| Moderate | Well-controlled | <6 months | +25 to +50 points |
| Moderate | Well-controlled | 6-12 months | 0 to +25 points |
| Moderate | Well-controlled | >12 months | 0 to +25 points |
| Severe | Well-controlled | <12 months | +50 to +75 points |
| Severe | Well-controlled | 1-2 years | +25 to +50 points |
| Severe | Well-controlled | >2 years | 0 to +25 points |
| Any | Partially controlled | Any | Add +25 to +50 points to above |

**Modifying Factors**:
- Occupational impairment: +25 points
- Significant avoidance behaviors: +25 points
- Consistent follow-up with provider: -25 points
- Poor treatment compliance: +25 points
- Comorbid depression: +25 to +50 points

### Obsessive-Compulsive Disorder (OCD)

| Severity | Treatment Status | Duration of Stability | Points |
|----------|------------------|----------------------|--------|
| Mild | Well-controlled | <6 months | +25 to +50 points |
| Mild | Well-controlled | 6-12 months | 0 to +25 points |
| Mild | Well-controlled | >12 months | 0 to +25 points |
| Moderate | Well-controlled | <12 months | +50 to +75 points |
| Moderate | Well-controlled | 1-2 years | +25 to +50 points |
| Moderate | Well-controlled | >2 years | 0 to +25 points |
| Severe | Well-controlled | <2 years | +50 to +75 points |
| Severe | Well-controlled | 2-5 years | +50 to +75 points |
| Severe | Well-controlled | >5 years | +25 to +50 points |
| Any | Partially controlled | Any | Add +25 to +50 points to above |

**Modifying Factors**:
- Multiple medication trials needed: +25 points
- History of hospitalization: +50 points
- Consistent follow-up with provider: -25 points
- Poor treatment compliance: +25 points
- Significant functional impairment: +25 to +50 points

## Postpone/Decline Criteria

### Postpone

1. Recent diagnosis (<3 months) without established treatment plan
2. Recent hospitalization for anxiety (<3 months)
3. Recent change in medication regimen (<3 months)
4. Severe symptoms currently impacting daily functioning
5. Pending psychiatric evaluation
6. Recent exacerbation requiring intensive treatment

### Decline

1. Severe, treatment-resistant anxiety with multiple failed treatments
2. Current hospitalization for anxiety
3. Severe anxiety causing long-term disability
4. Severe anxiety with active substance abuse
5. Demonstrated non-compliance with essential treatment
6. Severe anxiety with recurrent self-harm behaviors

## Medication Considerations

| Medication Category | Examples | Underwriting Significance |
|--------------------|----------|---------------------------|
| **Selective Serotonin Reuptake Inhibitors (SSRIs)** | Fluoxetine (Prozac), Sertraline (Zoloft), Escitalopram (Lexapro) | First-line treatment; generally favorable if stable |
| **Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)** | Venlafaxine (Effexor), Duloxetine (Cymbalta) | May indicate more complex anxiety or comorbid conditions |
| **Benzodiazepines** | Alprazolam (Xanax), Clonazepam (Klonopin), Lorazepam (Ativan) | Short-term or as-needed use may be acceptable; long-term daily use may indicate more severe anxiety |
| **Buspirone** | Buspar | Generally favorable; often used for GAD |
| **Beta Blockers** | Propranolol, Atenolol | Often used for performance anxiety; generally favorable |
| **Atypical Antipsychotics** | Quetiapine (Seroquel), Aripiprazole (Abilify) | May indicate severe or treatment-resistant anxiety |
| **Tricyclic Antidepressants** | Imipramine, Clomipramine | May indicate treatment-resistant anxiety or specific conditions like OCD |
| **Multiple Medications** | Combination therapy | Indicates more difficult-to-treat anxiety |

## Comorbidity Factors

The following conditions may increase anxiety disorder ratings:

| Comorbidity | Points |
|-------------|-------------------|
| Depression | +25 to +75 points |
| Substance use disorders | +50 to +100 points |
| Personality disorders | +25 to +75 points |
| Post-traumatic stress disorder | +25 to +75 points |
| Eating disorders | +25 to +50 points |
| Bipolar disorder | +50 to +100 points |
| Chronic medical conditions | +25 points |
| Chronic pain | +25 points |

## Improvement Factors

Ratings may be improved with:

1. **Treatment stability**:
   - Longer duration of symptom control
   - Stable medication regimen
   - Regular follow-up with mental health provider

2. **Functional recovery**:
   - Return to work/school
   - Engagement in social activities
   - Reduction in avoidance behaviors
   - Independent living

3. **Risk reduction**:
   - Decreased frequency/severity of panic attacks
   - Effective coping strategies
   - Strong support system
   - Lifestyle modifications (exercise, stress management)

4. **Insight and adherence**:
   - Understanding of condition
   - Medication compliance
   - Recognition of triggers
   - Engagement in therapy

## Special Considerations

### Post-Traumatic Stress Disorder (PTSD)

| Severity | Treatment Status | Duration of Stability | Points |
|----------|------------------|----------------------|--------|
| Mild | Well-controlled | <12 months | +50 to +75 points |
| Mild | Well-controlled | 1-3 years | +25 to +50 points |
| Mild | Well-controlled | >3 years | 0 to +25 points |
| Moderate | Well-controlled | <2 years | +50 to +75 points |
| Moderate | Well-controlled | 2-5 years | +50 to +75 points |
| Moderate | Well-controlled | >5 years | +25 to +50 points |
| Severe | Well-controlled | <3 years | +75 points |
| Severe | Well-controlled | 3-7 years | +50 to +75 points |
| Severe | Well-controlled | >7 years | +50 to +75 points |
| Any | Partially controlled | Any | Add +25 to +50 points to above |

**Modifying Factors**:
- Combat-related: +25 points
- History of hospitalization: +25 points
- Comorbid substance abuse: +50 points
- Consistent follow-up with provider: -25 points

### Anxiety in Children/Adolescents with Adult Stability

| Childhood Diagnosis | Adult Status | Points |
|--------------------|--------------|--------|
| Mild-Moderate | Resolved, no treatment >2 years | Standard |
| Mild-Moderate | Well-controlled, minimal treatment | 0 to +25 points |
| Severe | Resolved, no treatment >5 years | 0 to +25 points |
| Severe | Well-controlled, ongoing treatment | 0 to +25 points |
| Any | Partially controlled | +25 to +50 points |

### Adjustment Disorder with Anxiety

| Duration | Precipitating Event Status | Points |
|----------|---------------------------|--------|
| <6 months | Ongoing stressor | 0 to +25 points |
| <6 months | Resolved stressor | 0 to +25 points |
| 6-12 months | Ongoing stressor | +25 to +50 points |
| 6-12 months | Resolved stressor | 0 to +25 points |
| >12 months | Any | Rate as Generalized Anxiety Disorder |

### Anxiety Secondary to Medical Condition

| Primary Condition Status | Anxiety Status | Points |
|--------------------------|---------------|--------|
| Resolved/well-controlled | Resolved | Rate for primary condition |
| Resolved/well-controlled | Well-controlled | Rate for primary condition +25 points |
| Resolved/well-controlled | Poorly controlled | Rate for primary condition +50 points |
| Poorly controlled | Any | Rate for primary condition +50 to +75 points |

### Treatment-Resistant Anxiety

For cases with:
- Failed response to â‰¥2 adequate medication trials
- Augmentation strategies required
- Specialty psychiatric care

Consider: +50 to +100 points based on:
- Current symptom control
- Functional status
- Treatment compliance
- Duration of stability
